Skip to main content
RIBOMIC Inc. logo

RIBOMIC Inc. — Investor Relations & Filings

Ticker · 4591 ISIN · JP3974850004 T Manufacturing
Open in API
Filings indexed 70 across all filing types
Latest filing 2021-06-30 Regulatory Filings
Country JP Japan
Listing T 4591

About RIBOMIC Inc.

https://www.ribomic.com/eng/

RIBOMIC Inc. is a biopharmaceutical company engaged in the discovery and development of novel molecular-targeted therapeutics using its proprietary RNA aptamer technology. The company's core drug discovery platform, the RiboART System (Ribomic Aptamer Refined Therapeutics System), enables the creation of aptamers that bind to target molecules with high affinity and specificity. RIBOMIC's development pipeline focuses on addressing significant unmet medical needs in various therapeutic areas. Key clinical programs include potential treatments for ophthalmic conditions, such as wet age-related macular degeneration, and rare genetic disorders like achondroplasia.

Recent filings

Filing Released Lang Actions
内部統制報告書－第18期(令和2年4月1日－令和3年3月31日)
Regulatory Filings
2021-06-30 Japanese
確認書
Regulatory Filings
2021-06-30 Japanese
有価証券報告書－第18期(令和2年4月1日－令和3年3月31日)
Annual Report
2021-06-30 Japanese
四半期報告書－第18期第3四半期(令和2年10月1日－令和2年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, management analysis (MDA), and operational updates for the third quarter of the fiscal year. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-02-12 Japanese
四半期報告書－第18期第2四半期(令和2年7月1日－令和2年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the second quarter of the 18th fiscal period, filed by RIBOMIC Inc. with the Kanto Local Finance Bureau on November 13, 2020. It contains detailed financial statements, management analysis (MDA), and operational updates for the period from July 1, 2020, to September 30, 2020. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. Q2 2020
2020-11-13 Japanese
四半期報告書－第18期第1四半期(令和2年4月1日－令和2年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a '第１四半期報告書' (First Quarter Report) for the company '株式会社リボミック' (RIBOMIC Inc.), covering the period from April 1, 2020, to June 30, 2020. It includes detailed financial statements, management analysis, and share information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-08-07 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.